This regulation may be cited as the Public Health (Medicinal Cannabis) and Other Legislation Amendment Regulation 2018.
Part 2 Amendment of Health (Drugs and Poisons) Regulation 1996
This part amends the Health (Drugs and Poisons) Regulation 1996.
3Amendment of s 78A (Approved drug–nabiximols)
(1)Section 78A(1)(b)—
omit.(2)Section 78A(1)(c)(i), ‘prescribed’—
omit, insert—compliant
(3)Section 78A(1)(c)—
renumber as section 78A(1)(b).(4)Section 78A(2), from ‘practitioner,’—
omit, insert—practitioner includes a registrar working under the direction of a specialist medical practitioner.
(5)Section 78A(3)—
insert—chronic non-cancer pain means pain, persisting more than 3 months, that is not associated with cancer.(6)Section 78A(3), definition prescribed patient—
insert—(e)a person experiencing chronic non-cancer pain.(7)Section 78A(3), definition prescribed specialist medical practitioner—
omit.
4Amendment of s 78B (Exemptions for some acts involving regulated controlled drugs)
Section 78B(2) to (4)—
omit.
Part 3 Amendment of Public Health (Medicinal Cannabis) Regulation 2017
This part amends the Public Health (Medicinal Cannabis) Regulation 2017.
6Amendment of s 27 (Form of wholesaling approval)
Section 27(a), ‘and professional qualifications’—
omit.
7Amendment of s 54 (Prescribed specialist medical practitioners—Act, s 52(1)(a))
Section 54(1)—
omit, insert—(1)For section 52(1)(a) of the Act, all compliant specialist medical practitioners are prescribed.
8Amendment of s 55 (Prescribed classes of patients—Act, s 52(2)(a))
(1)Section 55(1)—
insert—(e)persons experiencing chronic non-cancer pain.(2)Section 55(2)—
insert—chronic non-cancer pain means pain, persisting more than 3 months, that is not associated with cancer.
9Amendment of s 89 (Dealing with prescriptions)
Section 89(4), ‘72 hours’—
omit, insert—7 days
10Amendment of s 127 (Patient-class prescribers)
Section 127(2)—
omit, insert—(2)If the chief executive requests that a patient-class prescriber provide a treatment report for an eligible patient the patient-class prescriber is treating with medicinal cannabis, the patient-class prescriber must provide the report to the chief executive within the time stated in the request.Maximum penalty—20 penalty units.